Toxoplasma gondii GRA16 enhances the inhibitory effects of standard DNA-damaging chemotherapeutics in liver, pancreatic, and colorectal cancer cells
{{output}}
Dense granule protein 16 (GRA16), an effector protein from Toxoplasma gondii, has been reported to enhance antitumor responses in several malignancies. However, whether GRA16 can enhance the inhibitory effects of standard anticancer drugs across diverse cancer... ...
